Filing Flows › AbbVie (ABBV) › Net income
AbbVie (ABBV) net income by quarter
AbbVie's net income was $4.2B in Q3 2026 (third quarter 2026), +17% from Q2 2026. Over the last 7 quarters it ranged from $188M (Q3 2025) to $4.2B (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $4.2B | +17% | 22× |
| Q2 2026 | $3.6B | +419% | +284% |
| Q1 2026 | $697M | -62% | -46% |
| Q4 2025 | $1.8B | +865% | — |
| Q3 2025 | $188M | -80% | — |
| Q2 2025 | $941M | -27% | — |
| Q1 2025 | $1.3B | — | — |
Q3 2026 at a glance
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
Questions
What is AbbVie's net income?
AbbVie's net income was $4.2B in Q3 2026 (third quarter 2026), +17% from Q2 2026.
How has AbbVie's net income changed?
Over the last 7 quarters it ranged from $188M (Q3 2025) to $4.2B (Q3 2026).